Lo Talks Drug Development, Investment
Andrew Lo with the MIT Sloan School of Management recent discussed with Evidence-Based Oncology some potential… Read more
HEOR Feature
Featured
Trump Administration Could Narrow Focus on Drug Prices
The Trump administration could begin zeroing in on Medicare Part B spending next year, according to a FierceHealthcare report.
Bernstein analysts… Read more
Frakt Looks at Pros, Cons of Price Cutting Strategies
Partnered Evidence-Based Policy Resource Center Director Austin Frakt in a recent article published on the New York Times offers a look at some of the… Read more
Joint Investigation Finds Medical Journals Should Bolster Vetting Process
A joint investigation by ProPublica and the New York Times suggests medical journals need to focus their efforts on strengthening their vetting… Read more
